CG
KIN

Cutler Group’s Kindred Biosciences, Inc. KIN Stock Holding History

Cutler Group’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,200
Closed -$5K – 5480
2020
Q2 		$5K Buy
1,200
+400
+50% +$1.79K ﹤0.01% 3391
2020
Q1 		$3K Buy
+800
New +$6.79K ﹤0.01% 3403
2018
Q4 		– Sell
-400
Closed -$5K – 4868
2018
Q3 		$5K Sell
400
-1,100
-73% -$14.9K ﹤0.01% 3107
2018
Q2 		$15K Buy
1,500
+1,400
+1,400% +$13.7K ﹤0.01% 2413
2018
Q1 		$0 Sell
100
-600
-86% -$5.26K ﹤0.01% 5573
2017
Q4 		$6K Buy
+700
New +$5.47K ﹤0.01% 3555
2017
Q2 		– Sell
-200
Closed -$1K – 7397
2017
Q1 		$1K Sell
200
-3,370
-94% -$21.1K ﹤0.01% 6120
2016
Q4 		$15K Hold
3,570
– – ﹤0.01% 3791
2016
Q3 		$17K Hold
3,570
– – ﹤0.01% 3621
2016
Q2 		$12K Hold
3,570
– – ﹤0.01% 3973
2016
Q1 		$12K Hold
3,570
– – ﹤0.01% 3897
2015
Q4 		$12K Buy
+3,570
New +$16.6K ﹤0.01% 3980

Other funds holding KIN

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cutler Group's KIN Position: Q3 2020 in Review

Cutler Group sold out of Kindred Biosciences, Inc. (KIN) in Q3 2020, closing a stake of 1,200 shares — an estimated $5K sold.

Cutler Group first reported a position in KIN in Q4 2015 and held it in 12 quarters. The position peaked at $17K in Q3 2016. 77 funds tracked by Wall St. Rank hold KIN as of Q3 2020.

  • Cutler Group reported no remaining Kindred Biosciences, Inc. position as of Q3 2020 after selling out during the quarter.
  • Cutler Group sold 1,200 Kindred Biosciences, Inc. shares in Q3 2020, an estimated $5K.
  • Cutler Group first reported a position in Kindred Biosciences, Inc. in Q4 2015 and held it in 12 quarters.
  • Cutler Group's Kindred Biosciences, Inc. position peaked at $17K in Q3 2016.
  • 77 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2020.

Based on Cutler Group's 13F filing for Q3 2020, filed 27 Oct 2020.